# Peijia Medical Technology (Suzhou) Co., Ltd.: Not applicable (device, behavioral) study in Aortic Stenosis (150 participants)

**Score:** 75/100

| Field | Value |
|---|---|
| Sponsor | Peijia Medical Technology (Suzhou) Co., Ltd. |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Target Value Study to Evaluate the Safety and Efficacy of the Taurus NXT® Transcatheter Aortic Valve System for the Treatment of Severe Calcific Aortic Stenosis |
| NCT ID | NCT07908225 |
| Phase | Not applicable (device, behavioral) |
| Status | active not recruiting |
| Conditions | Aortic Stenosis |
| Intervention types | device |
| Target enrollment | 150 |
| Site countries | China |
| Posted | 2026-11-02 |
| Planned start | 2021-09-10 |
| Event | Newly registered study |
| Event date | 2026-11-02 |

## Why this score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- 150 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07908225). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.